ALSGEN INC has a total of 11 patent applications. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals are CHRYSALIS PHARMA AG, PARSROOS CO and PLETNEV VLADIMIR VLADIMIROVICH.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Scott Sean | 10 |
#2 | Benjamin Daniel | 8 |
#3 | Rex Brian T | 2 |
#4 | Bracken Justin D | 2 |
#5 | Benjamin Daniel E | 2 |
#6 | Errico Monica A | 2 |
#7 | Henrie Robert N Ii | 1 |
#8 | Sean Scott | 1 |
#9 | Henrie Robert N | 1 |
#10 | Daniel Benjamin | 1 |
Publication | Filing date | Title |
---|---|---|
US2007135437A1 | Modulation of neurodegenerative diseases | |
CA2600067A1 | Treatment of amyotrophic lateral sclerosis with pyrimethamine and analogues 6 | |
CN101232888A | Treatment of amyotrophic lateral sclerosis with norethindrone and analogues |